Identification of the HNA-3a antigen

Blood

Volumn 115, Issue 10, 2010, Pages 1863-

  Silliman, Christopher C ^a   Stroncek, David ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD40 LIGAND; HLA ANTIBODY; HUMAN NEUTROPHIL ANTIGEN 3A; HUMAN NEUTROPHIL ANTIGEN 3B; UNCLASSIFIED DRUG;

ALLELE; APHERESIS; BLOOD DONOR; HUMAN; MULTIPARA; NOTE; PRIORITY JOURNAL; SCREENING TEST; SOLID; TRANSFUSION RELATED ACUTE LUNG INJURY;

EID: 77950375986     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-12-257527     Document Type: Note

References (10)

1. Curtis BR, Cox NJ, Sullivan MJ, et al. The neutrophil alloantigen HNA-3a (5b) is located on choline transporterlike protein 2 (CTL2) and appears to be encoded by an R>Q154 amino acid substitution. Blood. 2010;115(10): 2073-2076.
2. Davoren A, Curtis BR, Shulman IA, et al. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion. 2003;43(5):641-645. (Pubitemid 36506361)
3. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA. 2002; 287(15):1968-1971. (Pubitemid 34309755)
4. Reil A, Keller-Stanislawski B, Gunay S, Bux J. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang. 2008;95(4):313-317.
5. Silliman CC, Curtis BR, Kopko PM, et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood. 2007;109(4):1752-1755.
6. Bux J, Wesche J, Hammer E, Voelker U, Reil A, Greinacher A. Characterization of the human neutrophil alloantigen (HNA) 3a [abstract]. Blood. 2009;114(22):16. Abstract 24.
7. Sachs UJ, Link E, Hofmann C, Wasel W, Bein G. Screening of multiparous women to avoid transfusionrelated acute lung injury: a single centre experience. Transfus Med. 2008;18(6):348-354.
8. Densmore TL, Goodnough LT, Ali S, Dynis M, Chaplin H. Prevalence of HLA sensitization in female apheresis donors. Transfusion. 1999;39(1):103-106. (Pubitemid 29065966)
9. Khan SY, Kelher MR, Heal JM, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood. 2006;108(7):2455-2462.
10. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101(2): 454-462. (Pubitemid 36077563)